|
Leadership and Team membersChairs:
Michal Bassani-Sternberg, Ph.D University of Lausanne (CHUV), Switzerland
Nicola Ternette, Ph.D Oxford, United Kingdom Executive Committee members:
Annika Nelde, Ph.D Tübingen, Germany
Pouya Faridi, Pharm.D, Ph.D Monash University, Melbourne, Australia
Wei Wu, Ph.D Utrecht University, Utrecht, The Netherlands
Krystel Vincent, Ph.D University of Montreal, Quebec, Canada
Jennifer G. Abelin, Ph.D Cambridge, MA, USA | The collection of peptides presented to the cell surface by class I and class II human leukocyte antigen (HLA) molecules are referred to as the immunopeptidome and are of great importance for basic and translational science. For basic science, the comprehensive analysis of the immunopeptidome is a critical component for understanding the immune system; for translational science, exact knowledge of the immunopeptidome can directly fuel and guide the development of next-generation vaccines, cell therapies and immunotherapies against autoimmunity, infectious diseases and cancers. HUPO-HIPP started in 2015. The long-term goal of HUPO-HIPP is to map the entire repertoire of peptides presented by HLA molecules using mass spectrometry technologies, and make its robust analysis accessible to any immunologist, clinical-investigator and other researchers. Pillars of the HUPO-HIPP program are: (1) method and technology development, (2) standardization, (3) effective data sharing, and (4) education. Current lines of work:
HIPP membership: If you would like to become a member of HUPO-HIPP complete the attached Membership Form. | Announcements & upcoming eventsSave the date: 3rd HUPO-HIPP Webinar May 5, 2022 @ 3PM CEST Confirmed speakers: Andreas Schlosser (University of Würzburg) Shelly Kalaora (Weizmann Institute of Science) Michal Bassani-Stenberg (Ludwig Institute for Cancer Research) 2nd HUPO-HIPP summer school 6-9 September 2022 (Oxford, UK) |